Skip to content
Homepage
Author:
Paragonix Technologies, Inc.
Posted Date:
June 25, 2026
Paragonix LIVERguard System Shown to Safely Extend Ischemic Times Enabling Expanded Utilization of Donor Livers
Paragonix Technologies, Inc.
June 25, 2026
Paragonix to Present New Organ Preservation Research at the 2026 American Transplant Congress Annual Meeting
Paragonix Technologies, Inc.
June 4, 2026
Paragonix Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization
Paragonix Technologies, Inc.
May 30, 2026
UC Health Expands Access to Liver Transplantation with the Paragonix LIVERguard® System
Paragonix Technologies, Inc.
May 29, 2026
New Lung Preservation Studies Showcase Key Insights of Optimizing Temperature and Airway Pressure Control
Paragonix Technologies, Inc.
May 26, 2026
Paragonix Announces Technology Upgrade to Industry Leading SherpaPak® Cardiac Transport System
Paragonix Technologies, Inc.
May 25, 2026
Paragonix Reaches 1,000 KidneyVault System Cases, Setting a New Standard in Kidney Transport
Paragonix Technologies, Inc.
May 21, 2026
Paragonix to Present Extensive Organ Transplant Research at the 46th Annual International Society of Heart and Lung Transplantation Meeting
Paragonix Technologies, Inc.
April 1, 2026
Bari Polyclinic Becomes Europe’s Largest Heart Transplant Center in 2025, Powered by Paragonix Advanced Preservation
Paragonix Technologies, Inc.
February 12, 2026
Paragonix KidneyVault® System Enables Reallocation of Donor Kidney After Late Decline and Extended Ischemic Time
Paragonix Technologies, Inc.
February 7, 2026
